Jul 09, 2026
7:5
For every 5 shares held, investors received 7. The price per share adjusted from $39.33 to $28.09.
The split itself did not change the total investment value.
Ningbo Menovo Pharmaceutical Co., Ltd. Class A (SSE:603538) operates in the Pharmaceuticals: major industry.
Ningbo Menovo Pharmaceutical Co., Ltd. Class A company overviewNingbo Menovo Pharmaceutical Co., Ltd. Class A's most recent stock split was on July 9, 2026. It was a 7-for-5 forward split, so shareholders received 7 shares for every 5 they held.
Ningbo Menovo Pharmaceutical Co., Ltd. Class A (SSE:603538) has split its stock 3 times: a 6-for-5 split on July 9, 2018, a 563-for-403 split on June 8, 2022, and a 7-for-5 split on July 9, 2026.
Ningbo Menovo Pharmaceutical Co., Ltd. Class A has split its stock 3 times. This history records 3 forward splits between July 9, 2018 and July 9, 2026.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Ningbo Menovo Pharmaceutical Co., Ltd. Class A's 7-for-5 split on July 9, 2026, every 5 shares became 7 shares.
Ningbo Menovo Pharmaceutical Co., Ltd. Class A has not announced a new split in our records. Its most recent split was on July 9, 2026, less than a year ago. Companies announce splits in advance, and any new SSE:603538 split will appear on this page.
Already premium?